STK15 polymorphism and breast cancer risk in a population-based study

Carcinogenesis

Volumn 25, Issue 11, 2004, Pages 2149-2153

  Egan, Kathleen M ^f   Newcomb, Polly A ^a   Ambrosone, Christine B ^b   Trentham Dietz, Amy ^c   Titus Ernstoff, Linda ^d   Hampton, John M ^e   Kimura, Makoto T ^b   Nagase, Hiroki ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d NORRIS COTTON CANCER CENTER   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT;

AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HALF-LIFE; HUMANS; INCIDENCE; MATERNAL AGE; MITOSIS; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; UBIQUITIN; UNITED STATES;

EID: 8844250780     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh231     Document Type: Article

References (20)

1. Ewart-Toland,A., Briassouli,P., de Koning,J.P. et al. (2003) Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nature Genet., 34 403-412.
2. Nigg,E.A. (2002) Centrosome aberrations: cause or consequence of cancer progression? Nature Rev. Cancer, 2, 815-825.
3. Neben,K., Korshunov,A., Benner,A., Wrobel,G., Hahn,M., Kokocinski,F., Golanov,A., Joos,S. and Lichter,P. (2004) Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res., 64, 3103-3111.
4. Miyoshi,Y., Iwao,K., Egawa,C. and Noguchi,S. (2001) Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int. J. Cancer, 92, 370-373.
5. Katayama,H., Sasai,K., Kawai,H. et al. (2004) Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genet., 36, 55-62.
6. Pfleger,C.M. and Kirschner,M.W. (2000) The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev., 14, 655-665.
7. Honda,K., Mihara,H., Kato,Y., Yamaguchi,A., Tanaka,H., Yasuda,H., Furukawa,K. and Urano,T. (2000) Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway. Oncogene, 19, 2812-2819.
8. Dutertre,S., Descamps,S. and Prigent,C. (2002) On the role of aurora-A in centrosome function. Oncogene, 21, 6175-6193.
9. Kimura,M., Kotani,S., Hattori,T., Sumi,N., Yoshioka,T., Todokoro,K. and Okano,Y. (1997) Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ip11. J. Biol. Chem., 272, 13766-13771.
10. Littlepage,L.E. and Ruderman,J.V. (2002) Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit. Genes Dev., 16, 2274-2285.
11. Bischoff,J.R., Anderson,L., Zhu,Y. et al. (1998) A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J., 17, 3052-3065.
12. Hirakawa,M., Tanaka,T., Hashimoto,Y., Kuroda,M., Takagi,T. and Nakamura,Y. (2002) JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res., 30, 158-162.
13. Miao,X., Sun,T., Wang,Y., Zhang,X., Tan,W. and Lin,D. (2004) Functional STK15 Phe31Ile polymorphism is associated with the occurrence and advanced disease status of esophageal squamous cell carcinoma. Cancer Res., 64, 2680-2683.
14. DiCioccio,R.A., Song,H., Waterfall,C., Kimura,M.T., Nagase,H., McGuire,V., Hogdall,E. and Shah,M.N. (2004) Common polymorphisms in STK15 and ovarian cancer risk. Cancer Epidemiol. Biomarkers Prev., in press.
15. Newcomb,P.A., Titus-Ernstoff,L., Egan,K.M., Trentham-Dietz,A., Baron,J.A., Storer,B.E., Willett,W.C. and Stampfer,M.J. (2002) Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 593-600.
16. Zhao,J.H., Curtis,D. and Sham,P.C. (2000) Model-free analysis and permutation tests for allelic associations. Hum. Hered., 50 133-139.
17. Katayama,H., Sasai,K., Kawai,H. et al. (2004) Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genet., 36, 55-62.
18. Hoque,A., Carter,J., Xia,W., Hung,M.C., Sahin,A.A., Sen,S. and Lippman,S.M. (2003) Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol. Biomarkers Prev., 12, 1518-1522.
19. Tanaka,T., Kimura,M., Matsunaga,K., Fukada,D., Mori,H. and Okano,Y. (1999) Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res., 59, 2041-2044.
20. Persson,I. (2000) Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings. J. Steroid Biochem. Mol. Biol., 74, 357-364.